BIG-ENDOTHELIN-1 CONTRACTS RAT ISOLATED UTERUS VIA A PHOSPHORAMIDON-SENSITIVE ENDOTHELIN-ET(A) RECEPTOR-MEDIATED MECHANISM

被引:10
作者
RAE, GA [1 ]
CALIXTO, JB [1 ]
DORLEANSJUSTE, P [1 ]
机构
[1] UNIV SHERBROOKE, SCH MED, DEPT PHARMACOL, SHERBROOKE J1H 5N4, QUEBEC, CANADA
关键词
BIG-ENDOTHELIN-1; ENDOTHELIN-1; ENDOTHELIN-3; ENDOTHELIN-ET(A) RECEPTOR; BQ-123; PHOSPHORAMIDON; ENDOTHELIN-CONVERTING ENZYME; UTERUS (RAT);
D O I
10.1016/0014-2999(93)90888-O
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The presence of a phosphoramidon-sensitive endothelin-1-converting enzyme was investigated in the rat isolated uterus. Endothelin-1 and its precursor, big-endothelin-1, increased the rate of spontaneous contractions and caused tonic contractions. Responses to big-endothelin-1 had a slower start than those to endothelin-1. The tonic contraction induced by big-endothelin-1 (10 nM) was nearly abolished by phosphoramidon (100 muM), but the response to an equieffective concentration of endothelin-1 (3 nM) was not affected. Big-endothelin-1 (EC50 6.7 nM) was only 7-fold less potent than endothelin-1 (EC50 0.9 nM), whereas endothelin-3 was much less potent (EC50 > 100 nM). The endothelin ET(A) receptor antagonist, BQ-123 (40, 150 and 600 nM), induced graded rightward shifts of the concentration-response curve for endothelin-1. Schild analysis yielded a straight line with a slope not different from unity, and a pA2 value of 7.76. At 100 nM, BQ-123 specifically blocked responses to both endothelin-1 (3 nM) and big-endothelin-1 (10 nM), without modifying those to oxytocin (5 nM), acetylcholine (3 muM) or bradykinin (0.5 nM). Our results suggest the presence of phosphoramidon-sensitive endothelin-converting enzyme and demonstrate the occurrence of functional endothelin ET(A) receptors in the rat uterus.
引用
收藏
页码:113 / 119
页数:7
相关论文
共 35 条
[1]   CLONING AND CHARACTERIZATION OF CDNA-ENCODING HUMAN A-TYPE ENDOTHELIN RECEPTOR [J].
ADACHI, M ;
YANG, YY ;
FURUICHI, Y ;
MIYAMOTO, C .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 180 (03) :1265-1272
[2]   CLONING AND EXPRESSION OF A CDNA-ENCODING AN ENDOTHELIN RECEPTOR [J].
ARAI, H ;
HORI, S ;
ARAMORI, I ;
OHKUBO, H ;
NAKANISHI, S .
NATURE, 1990, 348 (6303) :730-732
[3]   SOME QUANTITATIVE USES OF DRUG ANTAGONISTS [J].
ARUNLAKSHANA, O ;
SCHILD, HO .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1959, 14 (01) :48-58
[4]   EFFECTS OF ENDOTHELINS, BAY-K-8644 AND OTHER OXYTOCICS IN NONPREGNANT AND LATE PREGNANT RAT ISOLATED UTERUS [J].
CALIXTO, JB ;
RAE, GA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 192 (01) :109-116
[5]   DIFFERENT PHARMACOLOGICAL PROFILES OF BIG-ENDOTHELIN-3 AND BIG-ENDOTHELIN-1 INVIVO AND INVITRO [J].
DORLEANSJUSTE, P ;
TELEMAQUE, S ;
CLAING, A .
BRITISH JOURNAL OF PHARMACOLOGY, 1991, 104 (02) :440-444
[6]   HUMAN BIG-ENDOTHELIN-1 AND ENDOTHELIN-1 RELEASE PROSTACYCLIN VIA THE ACTIVATION OF ET1 RECEPTORS IN THE RAT PERFUSED LUNG [J].
DORLEANSJUSTE, P ;
TELEMAQUE, S ;
CLAING, A ;
IHARA, M ;
YANO, M .
BRITISH JOURNAL OF PHARMACOLOGY, 1992, 105 (04) :773-775
[7]   ENDOTHELIN-1 GENE-EXPRESSION AND PROTEIN-BIOSYNTHESIS IN HUMAN ENDOMETRIUM - POTENTIAL MODULATOR OF ENDOMETRIAL BLOOD-FLOW [J].
ECONOMOS, K ;
MACDONALD, PC ;
CASEY, ML .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 74 (01) :14-19
[8]   INHIBITION OF BIOLOGICAL ACTIONS OF BIG ENDOTHELIN-1 BY PHOSPHORAMIDON [J].
FUKURODA, T ;
NOGUCHI, K ;
TSUCHIDA, S ;
NISHIKIBE, M ;
IKEMOTO, F ;
OKADA, K ;
YANO, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 172 (02) :390-395
[9]  
HEMSEN A, 1991, ACTA PHYSIOL SCAND, V142, P1
[10]  
HIRATA Y, 1990, EUR J PHARMACOL, V176, P225